Image Place holder

Christine S. Sam, MD


Specialty: Hematology/Oncology
Program: Senior Adult Oncology

Call 1-888-MOFFITT
(1-888-663-3488)

Call 1-888-MOFFITT
(1-888-663-3488)


Locations: Moffitt McKinley Outpatient Center
Overview

Cancer Types Treated: Anal Cancer, Bladder Cancer , Breast Cancer, Colorectal Cancer , Esophageal Cancer , Gallbladder Cancer , Kidney (Renal Cell) Cancer , Liver Cancer , Lung Cancer , Pancreatic Cancer , Prostate Cancer

Dr. Christine Sam is an Assistant Member in the Department of Individualized Cancer Management/Senior Adult Oncology Program.  Dr. Sam received her medical degree from Michigan State University College of Human Medicine in East Lansing. She completed an Internal Medicine Residency at University of Michigan Health Systems in Ann Arbor. She completed her Hematology and Medical Oncology Fellowship at Moffitt Cancer Center/University of South Florida Morsani College of Medicine in Tampa. Dr. Sam’s primary clinical interest is the treatment of cancer in older patients and developing care plans tailored to their individual needs. Her focus is the treatment of breast, gastrointestinal, and genitourinary malignancies. She is also engaged in improving the way we care for older patients with cancer through education of medical trainees and staff, increasing access to clinical trials, and quality improvement.

Education & Training

Board Certification:

  • Internal Medicine
  • Oncology
  • Hematology
  • Medical Oncology
  • Medical Oncology

Fellowship:

  • University of South Florida/Moffitt Cancer Center - Hematology and Medical Oncology

Residency:

  • University of Michigan Health Systems -

Medical School:

  • Michigan State Univeristy College of Human Medicine - MD
Participating Trials

CLINICAL TRIAL 19646
Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients with Metastatic HER-2+ Breast Cancer, Phase III
Condition: Breast
Intervention: Carvedilol; Not Applicable
Open

CLINICAL TRIAL 19840
ProSTAR: A Phase 1b/2 Study of CPI-1205, a Small Molecule Inhibitor of EZH2, Combined with Enzalutamide or Abiraterone/Prednisone in Patients with Metastatic Castration Resistant Prostate Cancer
Condition: Genitourinary
Intervention: Abiraterone acetate; CPI-1205; Enzalutamide; Zytiga (Abiraterone acetate); cobicistat; prednisone
Open

CLINICAL TRIAL 19874
Phase Ib Feasibility Trial of Neoadjuvant Nivolumab/Lirilumab in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
Condition: Genitourinary
Intervention: BMS-936558 (Nivolumab); Lirilumab; Nivolumab
Open

CLINICAL TRIAL 19851
A Phase 2, Multicenter, Single-Arm Trial of CV301 in Combination with PD-1/L1 Blockade in Patients with Locally Advanced or Metastatic Urothelial Bladder Cancer
Condition: Genitourinary
Intervention: Atezolizumab (Tecentriq); FPV-CV301; MVA-BN-CV301
Open

CLINICAL TRIAL 19473
Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Stage III-IVB Head and Neck Cancer with a Contraindication to Cisplatin
Condition: Head & Neck
Intervention: AMP-514 (Durvalumab); Cetuximab; Durvalumab; Erbitux (Cetuximab); MEDI4736 (Durvalumab)
Open

CLINICAL TRIAL 19945
A Phase II basket study of the oral selective pan-FGFR inhibitor Debio 1347 in subjects with solid tumors harboring a fusion of FGFR1, FGFR2 or FGFR3 "The FUZE Clinical Trial"
Condition: Genitourinary
Intervention: Debio 1347
Open

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.

Publications

  • Sam C, Desai P, Laber D, Patel A, Visweshwar N, Jaglal M. Pegylated bovine carboxyhaemoglobin utilisation in a thrombotic thrombocytopenic purpura patient. Transfus Med. 2017 Aug;27(4):300-302. Pubmedid: 28401611.
  • Nadal E, Chen G, Prensner JR, Shiratsuchi H, Sam C, Zhao L, Kalemkerian GP, Brenner D, Lin J, Reddy RM, Chang AC, Capellà G, Cardenal F, Beer DG, Ramnath N. KRAS-G12C mutation is associated with poor outcome in surgically resected lung adenocarcinoma. J Thorac Oncol. 2014 Oct;9(10):1513-1522. Pubmedid: 25170638.